Cis Lurasidone | CAS 139563-25-0 - Request Quote
Cis Lurasidone
| SZ CAT No: | SZ-L035013 |
| CAS No | 139563-25-0 |
| Mol.F. | C28H36N4O2S : HCl |
| Mol.Wt. | 492.7 : 36.5 |
| Inv. Status | In Stock |
| Rel. CAS No | 194861-82-0 (free base) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cis Lurasidone is chemically (Rel-(3aR,4S,7R,7aS)-2-(((1R,2S)-2-((4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl)hexahydro-1H-4,7- methanoisoindole-1,3(2H)-dione, hydrochloride) (as per USP). Cis Lurasidone is supplied with detailed characterization data compliant with regulatory guideline. Cis Lurasidone can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lurasidone.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 139563-25-0
Purchase 139563-25-0
Order 139563-25-0
Enquire 139563-25-0
price of 139563-25-0
139563-25-0 Supplier
139563-25-0 Manufacturer
139563-25-0 Exporter
buy high quality Cis Lurasidone
Purchase Cis Lurasidone
Cis Lurasidone suppliers
Cis Lurasidone manufacturers
Cis Lurasidone price
Order Cis Lurasidone
Enquire Cis Lurasidone
Cis Lurasidone cost
Cis Lurasidone Supplier
Cis Lurasidone Distributor
Cis Lurasidone for Method Validation
Lurasidone Reference Standard
Cis Lurasidone for ANDA Filing
Cis Lurasidone for Forced Degradation Studies
Cis Lurasidone Identification Standards
Cis Lurasidone for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


